US BANCORP \DE\ - FIVE PRIME THERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$4,000
+100.0%
1140.0%0.00%
Q4 2020$2,000114
+1040.0%
0.00%
Q4 2018$0
-100.0%
10
-86.7%
0.00%
Q3 2018$1,0000.0%75
-7.4%
0.00%
Q2 2018$1,0000.0%81
+125.0%
0.00%
Q3 2017$1,0000.0%360.0%0.00%
Q2 2017$1,000
-50.0%
36
-36.8%
0.00%
Q1 2017$2,000
-93.3%
57
-92.2%
0.00%
Q2 2016$30,000
+3.4%
731
+4.0%
0.00%
Q1 2016$29,000
+70.6%
703
+75.8%
0.00%
Q4 2015$17,000
+183.3%
4000.0%0.00%
Q3 2015$6,000
-40.0%
4000.0%0.00%
Q2 2015$10,0004000.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
BVF INC/IL 6,338,678$238,778,0008.95%
One Fin Capital Management LP 440,000$16,575,0006.37%
COMMODORE CAPITAL LP 361,344$13,612,0005.42%
Chicago Capital Management, LLC 295,864$11,145,0005.19%
Kellner Capital, LLC 226,876$8,546,0003.10%
HARVEST MANAGEMENT LLC 97,500$3,673,0002.20%
Rock Springs Capital Management LP 2,660,822$100,233,0002.19%
ALPINE ASSOCIATES MANAGEMENT INC. 2,007,700$75,630,0002.05%
NEXPOINT ASSET MANAGEMENT, L.P. 198,278$7,469,0001.95%
GARDNER LEWIS ASSET MANAGEMENT L P 236,565$8,911,0001.60%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders